Clinical Trial Update: Study of Trivalent and Bivalent (Types 1 & 2) Novel Oral Poliomyelitis Vaccines [Phase 1, Phase 2]

View source ↗

Summary

The document reports a Phase 1/2 clinical trial evaluating trivalent and bivalent novel oral poliomyelitis vaccines, with recruitment currently ongoing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Poliomyelitis

Drugs mentioned

• Bivalent novel oral poliomyelitis vaccine (Types 1 & 2)
• Trivalent novel oral poliomyelitis vaccine

Snippet

Sponsor: PATH | Conditions: Poliomyelitis | Phase 1, Phase 2 | Status: RECRUITING